Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Capital-Expenditures" stands at 33.90 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2024.
Kyowa Kirin Co Ltd's second quarter result of 8.73 Billion JPY for the item "Capital Expenditures" represents a decrease of -28.62 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 8.73 Billion JPY for the item "Capital Expenditures" represents a decrease of -66.97 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 33.90 Billion JPY for the item "Capital Expenditures" represents a decrease of -34.30 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -34.94 percent compared to the value the year prior.
The 1 year change in percent is -34.94.
The 3 year change in percent is 55.99.
The 5 year change in percent is 9.92.
The 10 year change in percent is -15.92.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Capital Expenditures | 905,699,262,464.00 |
![]() | Johnson & Johnson - Capital Expenditures | 486,508,953,600.00 |
![]() | AbbVie Inc - Capital Expenditures | 399,570,305,024.00 |
![]() | Roche Holding AG - Capital Expenditures | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Capital Expenditures | 280,205,508,085.11 |